BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33014189)

  • 1. Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients.
    Mei JC; Yan G; Mei SQ
    Dis Markers; 2020; 2020():8871746. PubMed ID: 33014189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
    Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
    Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Chen T; Zhu C; Wang X; Pan Y
    Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELF3-AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood.
    Song S; He X; Wang J; Wang R; Wang L; Zhao W; Wang Y; Zhang Y; Yu Z; Miao D; Xue Y
    Cancer Sci; 2021 Nov; 112(11):4553-4569. PubMed ID: 34418240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up‑regulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma.
    Shang F; Du SW; Ma XL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8950-8955. PubMed ID: 31696482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212.
    Zhang Z; Nong L; Chen ML; Gu XL; Zhao WW; Liu MH; Cheng WW
    Cancer Biother Radiopharm; 2022 Mar; 37(2):119-124. PubMed ID: 32598181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
    Gao Y; Zhu H; Mao Q
    J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma.
    You A; Gu J; Wang J; Li J; Zhang Y; Rao G; Ge X; Zhang K; Gao X; Wang D
    Neurologia (Engl Ed); 2024 May; 39(4):353-360. PubMed ID: 38616063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex.
    Li D; Shen L; Zhang X; Chen Z; Huang P; Huang C; Qin S
    J Exp Clin Cancer Res; 2022 Dec; 41(1):332. PubMed ID: 36457025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
    Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
    Chen XD; Zhu MX; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
    Zhang Q; Liu XJ; Li Y; Ying XW; Chen L
    Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
    Wei N; Wei H; Zhang H
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADAMTS9-AS1 knockdown suppresses cell proliferation and migration in glioma through downregulating Wnt/β-catenin signaling pathway.
    Zhou C; Zhao H; Wang S; Dong C; Yang F; Zhang J
    Bosn J Basic Med Sci; 2022 Jun; 22(3):395-402. PubMed ID: 34923953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.